FIR1 Antibody

What is FIR1 and why is it significant in research?

FIR1 (Fls2/Fls3-interacting receptor-like cytoplasmic kinase 1) is a protein involved in plant immunity signaling, particularly in tomato plants. It plays a crucial role in pattern-triggered immunity (PTI) activated by flagellin perception. FIR1 interacts with plant receptors Flagellin sensing 2 (Fls2) and Fls3, functioning as an early signaling component of the immune response pathway . The significance of FIR1 in research stems from its involvement in preinvasion immunity and its role in modulating jasmonic acid (JA) signaling during PTI activation, making it an important target for understanding plant-pathogen interactions and potentially developing disease-resistant crops .

In human research contexts, researchers sometimes work with FRA-1 (FOS-like antigen 1) antibodies, which target a member of the leucine zipper Fos family of transcription factors involved in cellular proliferation, differentiation, and transformation .

What are the primary applications for FIR1 antibodies in plant immunity research?

FIR1 antibodies are primarily used to investigate plant immune responses, particularly in studies of flagellin-triggered immunity. Key applications include:

• Protein interaction studies to verify binding between FIR1 and receptor proteins like Fls2 and Fls3 or signaling components like JAZ3

• Immunolocalization experiments to determine subcellular localization of FIR1 (primarily at the plasma membrane)

• Western blot analysis to detect and quantify FIR1 protein expression levels in wild-type versus mutant plants

• Co-immunoprecipitation assays to identify novel FIR1-interacting proteins in immune signaling pathways

• Tracking changes in FIR1 expression or phosphorylation status during pathogen infection

These applications help researchers understand how FIR1 mediates immune signaling and contributes to plant defense mechanisms against bacterial pathogens like Pseudomonas syringae.

How do I select the appropriate antibody type for FIR1 detection in my experimental system?

When selecting an antibody for FIR1 detection, consider the following methodological approach:

• Define your experimental goal: For localization studies, consider antibodies validated for immunohistochemistry. For protein quantification, select antibodies optimized for Western blotting.

• Consider antibody specificity: Choose antibodies raised against epitopes specific to your species of interest. For plant FIR1 studies, ensure the antibody recognizes the tomato protein rather than homologs from other species.

• Validate antibody cross-reactivity: If studying FIR1 in non-model plant species, test whether antibodies raised against tomato FIR1 cross-react with your species of interest.

• Select appropriate antibody format: For co-localization studies requiring fluorescence microscopy, choose primary antibodies compatible with fluorophore-conjugated secondary antibodies. For protein interaction studies, consider antibodies that won't interfere with protein-protein binding domains.

• Control for specificity: Always include appropriate controls, such as tissues from FIR1 knockout plants (like the CRISPR/Cas9-generated fir1 mutant lines described in the literature) to confirm antibody specificity .

How can I optimize antibody-based detection of FIR1 in plant tissue samples with high background?

High background is a common challenge when detecting plant proteins due to autofluorescence and cross-reactivity issues. For optimizing FIR1 detection:

• Sample preparation optimization:

  • Use fresh tissue samples when possible

  • For fixed tissues, optimize fixation time and conditions to preserve epitope accessibility while maintaining tissue structure

  • Consider antigen retrieval methods similar to those used for FRA-1 detection in melanoma tissues (heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic)

• Blocking optimization:

  • Test different blocking agents (BSA, normal serum, plant-specific blocking reagents)

  • Extend blocking time (3-5 hours) to reduce non-specific binding

  • Include detergents like 0.1% Triton X-100 to improve antibody penetration

• Antibody dilution optimization:

  • Perform titration experiments to determine optimal antibody concentration

  • For Western blot applications, start with approximately 0.2-1.0 μg/mL concentration (similar to the 0.2 μg/mL used for FRA-1 detection)

  • For immunohistochemistry, a concentration around 3 μg/mL may be appropriate (based on similar applications)

• Signal enhancement techniques:

  • Consider tyramide signal amplification if conventional detection methods yield weak signals

  • Use highly-sensitive detection systems similar to HRP-DAB Cell & Tissue Staining Kits

• Controls and validation:

  • Always run parallel experiments with fir1 mutant tissues as negative controls

  • Pre-absorb antibodies with recombinant FIR1 protein to confirm specificity

What experimental approaches can resolve contradictory results in FIR1 signaling studies?

When facing contradictory results in FIR1 signaling studies, consider these methodological approaches:

• Generate and validate multiple independent mutant lines:

  • Following the approach used in the literature, develop multiple independent CRISPR/Cas9-generated fir1 mutant lines (e.g., fir1-1 and fir1-2) to ensure phenotypes are consistent across different genetic lesions

  • Sequence the mutant lines to confirm the precise nature of the genetic modification

• Employ multiple infection methods:

  • Compare pathogen inoculation by different methods (dipping vs. vacuum-infiltration) as these can reveal different aspects of immunity

  • Research shows fir1 mutants are more susceptible to Pst DC3000 when inoculated by dipping but not by vacuum-infiltration, indicating Fir1's specific role in preinvasion immunity

• Use genetic complementation:

  • Reintroduce wild-type FIR1 into mutant backgrounds to confirm phenotype rescue

  • Create structure-function variants by introducing point mutations in key domains

• Employ different pathogen strains:

  • Use both wild-type pathogens and specific mutant strains (e.g., Pst DC3000 and flagellin-deficient Pst DC3000ΔfliC)

  • This approach revealed that Fir1 specifically contributes to flagellin-induced immunity

• Integrate multiple readouts of immunity:

  • Measure diverse immune responses (ROS production, gene expression, stomatal closure, bacterial growth)

  • The literature shows fir1 mutants had impaired ROS production and PR1b expression but normal MAP kinase phosphorylation, suggesting Fir1 regulates specific branches of immune signaling

• Analyze protein-protein interactions using multiple methods:

  • Combine in planta techniques (split-luciferase complementation) with in vitro approaches (pull-down assays)

  • This approach confirmed the interaction between Fir1 and JAZ3

How can I effectively study the dynamics of FIR1 protein-protein interactions in immune signaling?

To investigate FIR1 protein-protein interactions effectively:

• Multi-method validation approach:

  • Begin with yeast two-hybrid screening to identify potential interactors

  • Validate interactions in planta using split-luciferase complementation assays

  • Confirm direct interactions with in vitro pull-down assays using purified proteins

  • This comprehensive approach was successfully used to confirm Fir1 interaction with JAZ3

• Domain mapping strategy:

  • Generate truncated versions of FIR1 to identify specific interaction domains

  • Create point mutations in predicted interaction interfaces

  • Test these variants in interaction assays to define critical residues

• Dynamic interaction monitoring:

  • Use fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) to visualize interactions in living cells

  • Monitor changes in protein interactions following pathogen challenge or MAMP treatment

• Co-immunoprecipitation with stimulation time course:

  • Perform co-IP experiments at different time points after flagellin treatment

  • Western blot for interaction partners and phosphorylation status

  • This approach can reveal how interactions change during immune activation

• Protein complex analysis:

  • Use size exclusion chromatography to isolate native protein complexes

  • Combine with mass spectrometry to identify all components of FIR1-containing complexes

  • This can reveal whether FIR1 functions in different protein complexes under different conditions

What are the best approaches for analyzing FIR1-dependent gene expression changes?

For comprehensive analysis of FIR1-dependent gene expression:

• Experimental design considerations:

  • Include both wild-type and fir1 mutant plants

  • Establish multiple time points after immune elicitation (e.g., flagellin treatment)

  • Consider different tissues (leaves vs. roots) and developmental stages

• RNA-seq methodology:

  • Use RNA-seq to perform genome-wide expression analysis

  • This approach detected fewer differentially expressed genes in fir1 mutants compared to wild-type plants and revealed altered expression of jasmonic acid (JA)-related genes

  • Include biological replicates (minimum n=3) for statistical power

• Targeted gene expression analysis:

  • Validate RNA-seq findings with qRT-PCR for key genes

  • Focus on defense and hormone signaling genes (especially JA pathway components)

  • Include multiple reference genes for normalization

• Pathway enrichment analysis:

  • Perform gene ontology (GO) and pathway enrichment analysis

  • Identify enriched biological processes, molecular functions, and cellular components

  • Look for coordinated regulation of specific pathways (e.g., JA signaling)

• Integration with chromatin studies:

  • Consider ChIP-seq to identify target genes directly regulated by transcription factors downstream of FIR1

  • Investigate histone modifications associated with FIR1-dependent gene expression changes

• Validation with genetic and pharmacological approaches:

  • Confirm key findings using hormone treatments or genetic manipulation of identified pathway components

  • Test whether manipulating JA signaling can rescue fir1 mutant phenotypes

What controls should I include when using FIR1 antibodies in immunoprecipitation experiments?

For rigorous immunoprecipitation experiments with FIR1 antibodies, include these essential controls:

• Genetic controls:

  • Wild-type samples (positive control)

  • fir1 knockout samples (negative control) - such as the CRISPR/Cas9-generated fir1-1 and fir1-2 mutant lines

  • FIR1-overexpression lines (if available) to enhance signal detection

• Antibody controls:

  • Non-specific IgG from the same species as the FIR1 antibody

  • Pre-immune serum when using polyclonal antibodies

  • Antibody pre-absorption with recombinant FIR1 protein

• Sample preparation controls:

  • Input sample (pre-immunoprecipitation) to confirm target protein presence

  • Unbound fraction to assess immunoprecipitation efficiency

  • Mock immunoprecipitation without antibody

• Verification controls:

  • Reverse immunoprecipitation with antibodies against interacting partners

  • For known interactions (e.g., FIR1-JAZ3), confirm co-immunoprecipitation

  • Test negative control proteins known not to interact with FIR1 (e.g., JAZ7)

• Treatment controls:

  • Untreated vs. flagellin-treated samples to capture dynamic interactions

  • Time course experiments to track interaction changes during immune response

How can I distinguish between direct and indirect effects of FIR1 on immune signaling pathways?

To distinguish direct and indirect effects of FIR1 on immune signaling:

• Protein interaction network mapping:

  • Identify direct FIR1 interactors using yeast two-hybrid or in vitro binding assays

  • The direct interaction between FIR1 and JAZ3 was confirmed using pull-down assays with purified proteins

  • Construct an interaction network to visualize primary and secondary connections

• Temporal analysis of signaling events:

  • Establish the sequence of events following pathogen perception

  • Monitor phosphorylation cascades with phospho-specific antibodies

  • Compare timing of events in wild-type versus fir1 mutant plants

• Domain-specific mutations:

  • Generate FIR1 variants with mutations in specific functional domains

  • Test these variants for complementation of different immune phenotypes

  • Mutations that affect specific phenotypes but not others can help separate direct from indirect effects

• Inducible systems:

  • Use chemically-inducible FIR1 expression in fir1 mutant backgrounds

  • Identify immediate (likely direct) versus delayed (likely indirect) responses after induction

• Pharmacological interventions:

  • Use inhibitors of specific signaling components to determine pathway dependencies

  • Check if FIR1's effects on specific outputs are blocked by inhibiting intermediate components

• Genetic epistasis analysis:

  • Generate double mutants between fir1 and mutations in potential downstream components

  • The pattern of phenotypes in double mutants can reveal pathway relationships

What are the challenges in developing specific antibodies against plant FIR1 proteins?

Developing specific antibodies against plant FIR1 proteins presents several challenges:

• Epitope selection considerations:

  • Plant protein families often have high sequence similarity between members

  • Choose unique epitopes that distinguish FIR1 from other receptor-like cytoplasmic kinases

  • Target regions corresponding to amino acids 146-247 (as was successful for FRA-1)

  • Avoid highly conserved kinase domains unless specificity can be confirmed

• Expression system optimization:

  • E. coli expression systems may work well for producing recombinant FIR1 fragments

  • E. coli-derived recombinant proteins were successfully used for FRA-1 antibody production

  • Consider proper folding and potential post-translational modifications

• Validation across species:

  • Antibodies may exhibit different specificities across plant species

  • Validate cross-reactivity if studying FIR1 orthologs in species other than tomato

  • Test against closely related proteins to confirm specificity

• Specificity testing recommendations:

  • Test antibodies against wild-type and fir1 mutant tissue samples

  • Perform pre-absorption tests with recombinant FIR1 protein

  • Check for cross-reactivity with other RLCKs in the same family

• Application-specific optimization:

  • An antibody that works for Western blotting may not work for immunohistochemistry

  • Optimize fixation and antigen retrieval protocols for tissue samples

  • Test different antibody concentrations for each application (starting with 0.2-3 μg/mL range)

How can FIR1 research contribute to developing disease-resistant crops?

FIR1 research offers several promising avenues for crop improvement:

• Genetic engineering strategies:

  • Overexpress or modify FIR1 to enhance PTI responses

  • Target the FIR1-JAZ3 interaction to optimize the balance between growth and defense

  • Create crops with enhanced pre-invasion immunity and stomatal defense responses

• Pathway engineering approach:

  • Manipulate FIR1-dependent signaling pathways to enhance specific immune outputs

  • Fine-tune jasmonic acid signaling to balance pathogen resistance with growth

  • Create plants resistant to multiple pathogens by enhancing broad-spectrum immunity

• Marker-assisted breeding applications:

  • Develop molecular markers for FIR1 alleles associated with enhanced immunity

  • Screen germplasm collections for natural FIR1 variants with improved function

  • Introgress beneficial alleles into elite cultivars

• Experimental validation needed:

  • Test whether FIR1 enhancement increases resistance in field conditions

  • Evaluate potential trade-offs between enhanced immunity and agronomic traits

  • Assess durability of resistance across different pathogen strains and environmental conditions

• Translational research opportunities:

  • Identify FIR1 orthologs in major crop species beyond tomato

  • Determine if the FIR1-flagellin receptor interaction is conserved across plant families

  • Investigate whether FIR1 functions similarly in resistance to diverse pathogens beyond bacteria

What technological advances are needed to better study FIR1 dynamics during immune responses?

To advance FIR1 research, several technological developments would be beneficial:

• Advanced live cell imaging techniques:

  • Develop FIR1-fluorescent protein fusions that maintain full functionality

  • Use super-resolution microscopy to visualize FIR1 dynamics at the plasma membrane

  • Implement single-molecule tracking to monitor FIR1 movement during immune activation

• Phosphorylation-specific antibodies:

  • Develop antibodies that specifically recognize phosphorylated forms of FIR1

  • Map key phosphorylation sites that regulate FIR1 activity

  • Monitor changes in phosphorylation status during immune responses

• Inducible and tissue-specific expression systems:

  • Create systems for precise temporal and spatial control of FIR1 expression

  • Develop chemical-inducible systems to activate or inhibit FIR1 function

  • Generate tissue-specific promoters to study FIR1 function in different cell types

• Structural biology approaches:

  • Determine the three-dimensional structure of FIR1 alone and in complex with interacting partners

  • Identify structural changes that occur upon activation

  • Use structure-guided design to develop FIR1 variants with enhanced or novel functions

• Multi-omics integration platforms:

  • Combine transcriptomics, proteomics, metabolomics, and phenomics data

  • Develop computational models of FIR1-dependent signaling networks

  • Identify emergent properties not evident from single-omics approaches

How can researchers effectively compare FIR1 function across different plant species?

To compare FIR1 function across plant species effectively:

• Comparative genomics approach:

  • Identify FIR1 orthologs in different plant species using sequence similarity searches

  • Analyze conservation of key functional domains and regulatory regions

  • Construct phylogenetic trees to understand evolutionary relationships

• Complementation experiments:

  • Express FIR1 orthologs from different species in tomato fir1 mutants

  • Test whether these orthologs can restore immune function

  • Identify species-specific differences in functional complementation

• Domain swap experiments:

  • Create chimeric proteins containing domains from FIR1 orthologs of different species

  • Test these chimeras for interaction with known partners (e.g., Fls2, Fls3, JAZ3)

  • Identify domains responsible for species-specific functions

• Comparative interaction studies:

  • Test whether FIR1 orthologs interact with the same partners across species

  • Use split-luciferase complementation and pull-down assays as demonstrated for tomato FIR1

  • Identify conserved and divergent interaction networks

• Standardized phenotyping protocols:

  • Develop consistent methods to measure immune responses across species

  • Standardize pathogen inoculation techniques and environmental conditions

  • Create reference datasets for comparative analysis

• CRISPR/Cas9 mutant generation:

  • Generate equivalent fir1 mutations across multiple plant species

  • Compare phenotypic consequences in different genetic backgrounds

  • The CRISPR/Cas9 approach used successfully in tomato could be adapted for other species

How does FIR1 function compare with other receptor-like cytoplasmic kinases in plant immunity?

A comparative analysis of FIR1 with other receptor-like cytoplasmic kinases (RLCKs) reveals:

• Functional similarities and differences:

  • Like many RLCKs, FIR1 plays a role in pattern-triggered immunity (PTI)

  • FIR1 specifically mediates flagellin-induced immunity through interaction with Fls2/Fls3 receptors

  • Unlike some RLCKs involved in multiple MAMP responses, FIR1 appears more specialized for flagellin perception

• Signaling pathway positioning:

  • FIR1 affects ROS production and PR1b gene expression but not MAP kinase phosphorylation

  • This contrasts with some RLCKs that function upstream of MAPK cascades

  • FIR1 has a unique role in modulating jasmonic acid signaling during immunity

• Subcellular localization patterns:

  • FIR1 localizes to the plasma membrane, similar to many other RLCKs

  • This localization enables interaction with membrane-bound pattern recognition receptors

• Protein-protein interaction networks:

  • FIR1 uniquely interacts with JAZ3, linking PTI with jasmonic acid signaling

  • This distinguishes it from RLCKs that primarily interact with immune receptors and downstream MAPK cascades

• Physiological outcomes:

  • FIR1 specifically impacts pre-invasion immunity and stomatal defense

  • FIR1 negatively regulates jasmonic acid signaling during PTI

  • This regulatory function may be less common among other RLCKs

What experimental approaches can define the full spectrum of FIR1 functions in plant biology?

To comprehensively characterize FIR1 functions:

• Transcriptome analysis under diverse conditions:

  • Compare wild-type and fir1 mutant transcriptomes under:

    • Different pathogen challenges (bacterial, fungal, viral)

    • Abiotic stresses (drought, salt, temperature)

    • Developmental stages

  • RNA-seq analysis has already revealed FIR1's impact on gene expression during immunity

• Interactome mapping strategy:

  • Perform immunoprecipitation coupled with mass spectrometry (IP-MS)

  • Use proximity labeling techniques like BioID or TurboID

  • Compare interactomes under different conditions to identify dynamic interactions

  • The demonstrated interactions with Fls2, Fls3, and JAZ3 suggest a complex interactome

• Metabolomic profiling approach:

  • Compare metabolite profiles between wild-type and fir1 mutant plants

  • Focus on defense-related metabolites and hormones

  • Track changes in jasmonic acid and related compounds

• Hormone response characterization:

  • Test fir1 mutant responses to exogenous application of various plant hormones

  • Focus on jasmonic acid, salicylic acid, and ethylene

  • The altered JA responses in fir1 mutants suggest broader hormone crosstalk functions

• Developmental phenotyping:

  • Characterize fir1 mutant phenotypes throughout the plant life cycle

  • Document any differences in growth, development, or reproduction

  • Investigate potential trade-offs between immunity and growth

• Environmental response testing:

  • Evaluate fir1 mutant performance under various environmental conditions

  • Test responses to different light regimes, temperatures, and nutrient levels

  • Identify condition-specific functions

How should researchers interpret conflicting data between FIR1 studies in different experimental systems?

When confronting conflicting data between FIR1 studies:

• Systematic comparison of experimental conditions:

  • Create a detailed table documenting:

    • Plant growth conditions (light, temperature, humidity)

    • Age and developmental stage of plants

    • Experimental treatments (concentration, duration, application method)

    • Genetic background (wild-type reference, nature of mutations)

  • Minor variations in these factors can significantly impact results

• Genetic background evaluation:

  • Different fir1 mutant alleles may have distinct phenotypes

  • Compare the nature of mutations (e.g., the 4 bp vs. 135 bp deletions in fir1-1 and fir1-2)

  • Consider potential second-site mutations or background effects

• Methodology standardization approach:

  • Exchange biological materials between laboratories

  • Implement standardized protocols for key assays

  • Perform side-by-side experiments under identical conditions

• Multi-laboratory validation:

  • Organize collaborative studies with multiple independent labs

  • Use identical materials and protocols

  • Identify which results are reproducible across different settings

• Contextual interpretation framework:

  • Consider that seemingly conflicting results may reflect biological complexity

  • FIR1 function may be context-dependent (e.g., effective against some pathogens but not others)

  • The observation that fir1 mutants show phenotypes with some infection methods (dipping) but not others (vacuum infiltration) illustrates this context-dependence